Inflammatory response markers
tumor necrosis
TUMOR NECROSIS, INFLAMMATORY RESPONSE
Changes in serum IL-18, TNF-alpha, TGF- beta 1, TGF-beta 2 and CRP concentrations from T0 to T1 in the placebo and Camelina groups are presented in Supplementary Table S3.After the intervention, the authors observed a significant decrease in mean IL-18 concentration in the placebo group compared to the Camelina group (p <0.05) (Table Mean difference of inflammatory response markers at T1-T0IL18, interleukin - 18; TNFA, tumor necrosis factor-alpha; TGFB1, transforming growth factor-beta 1; TGFB 2, transforming growth factor-beta 2; CRP, C-reactive protein; SD, standard deviation. Data were reported as mean ± SD, t-test comparing placebo and intervention groups.Adjusted analyses showed no difference, even after considering smoking and eating habits as confounding factors.